Chemical Name:(2S)-2-Amino-N-[(1S,2S,4R)-7,7-dimethyl-1-[[[4-(2-methy
lphenyl)-1-piperazinyl]sulfonyl]methyl]bicyclo[2.2.1]he
pt-2-yl]-4-(methylsulfonyl)butanamide
Biological Activity:
Potent, non-peptide and orally active oxytocin
receptor antagonist (IC50 = 8.9 nM) that displays > 40-fold
selectivity over vasopressin V1a and V2 receptors (IC50
values are 370 and 570 nM respectively). Antagonises oxytocin-induced uterine
contractions in vitro and in vivo.
Williamset al
(1994) 1-(((7,7-dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine
(L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with
potential utility for managing preterm labor. J.Med.Chem. 37 565.
Mannet al (2003) Attenuation of PGE2α release in ewes infused with the
oxytocin antagonist L-368,899. Domest.Anim.Endocrinol. 25 255. Quattropaniet al (2005) Discovery and development of a new class of potent,
selective, orally active oxytocin receptor antagonist. J.Med.Chem. 48
7882.